info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > Endocrinology/Hormones > Androgen Receptor > Galeterone
Galeterone  
Catalog No. T6509    CAS 851983-85-2
Pack Size
Availability
Price/USD
Quantity
5mg
In Stock
97.00
50mg
In Stock
528.00
10mM * 1mL (in DMSO)
In Stock
123.00
10mg
In Stock
171.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.00% COA Datasheet
Biological Activity:

Product Description:

Galeterone is a selective CYP17 inhibitor and androgen receptor (AR) antagonist with IC50 of 300 nM and 384 nM, respectively, and is a potent inhibitor of human prostate tumor growth. Phase 2.

Target:
CYP17; Androgen Receptor;
Research Area:
Cancer
Chemical Information:
Molecular Weight 388.55
Formula C26H32N2O
CAS Number 851983-85-2
Solubility DMSO:24 mg/mL (61.76 mM)
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
Product Recommendations
  • LY3214996, LY-3214996 is a otent and selective, orally available inhibitor of extracellular signal-regulated ki...
  • Anlotinib Dihydrochloride, Anlotinib, also known as AL3818, is a receptor tyrosine kinase (RTK) inhibitor with potential antine...
  • TPX-0005, TPX-0005 is a potent ALK/ROS1/TRK inhibitor, with IC50 of 5.3 nM, 1.01 nM, 1.26 nM and 1.08 nM for S...
  • Sulfatinib, Sulfatinib may be a potent drug for cancer. It inhibits KDR and FGFR1 enzymatic activity, with IC50 ...
  • VLX1570, VLX1570 is a competitive inhibitor of proteasome DUB activity with IC50 ranging from 4.2 uM to 8.6 u...

 

Reference

If you have additional questions, Please send us a message. * Required